Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2016
Headcount
6
HQ
Ramat Gan, Israel
Sector
Health Tech & Life Sciences
About
Hide and Seq combines predictive and prognostic biomarkers to promote effective treatment for several types of cancer. The company is developing an in vitro diagnostic genomic signature that identifies which patients should be offered an alternative chemotherapy in first and second lines of treatment. Hide and Seq is developing a predictive assay for first-line therapy aimed at identifying chemotherapy resistance to paclitaxel (Taxol) in patients with metastatic ovarian cancer. A predictive genetic assay will offer physicians a personally tailored mode of treatment intended to increase treatment efficacy and survival.
Q&A
- What is Hide and Seq's primary focus?
- Hide and Seq focuses on personalized cancer therapy, combining predictive and prognostic biomarkers to promote effective treatment for several types of cancer.
- What specific diagnostic is Hide and Seq developing?
- Hide and Seq is developing an in vitro diagnostic genomic signature to identify patients who should be offered an alternative chemotherapy in first and second lines of treatment.
- What is the company's specific product in development for ovarian cancer?
- Hide and Seq is developing a predictive assay for first-line therapy aimed at identifying chemotherapy resistance to paclitaxel (Taxol) in patients with metastatic ovarian cancer.
- When was Hide and Seq founded?
- Hide and Seq was founded in April 2016.
- What is the current status of Hide and Seq?
- Hide and Seq is currently inactive, as of January 2018.
- How many employees does Hide and Seq have?
- Hide and Seq has 1-10 employees.
- What is Hide and Seq's primary sector?
- Hide and Seq's primary sector is Health Tech & Life Sciences.
- What is the company's current funding stage?
- Hide and Seq is in the Pre-Funding stage.
Team · 4
Founder · Co-founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareProvidersConsumersDemographics & FamilyWomen
Business model
B2B
Highlights
Verified
Tags
personalizationbiomarkersoncologypatientspersonalized-medicinechemotherapywomendoctorsmedical-technologiesdiagnosticswomen-healthcancertreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2016-4 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Jan 2018 |